Biocristin 1 mg Injection
$0.59
$0.47
Biocristin 1 mg Injection is an essential chemotherapy agent classified under the Vinca alkaloids, specifically designed to combat various types of cancer. This potent medication functions by inhibiting the growth and multiplication of cancer cells, effectively contributing to the overall treatment regimen for patients facing malignancies. Typically prescribed for conditions such as lymphoma and certain solid tumors, Biocristin helps in shrinking tumors and improving patient outcomes. It is crucial for healthcare providers to monitor patients closely for potential side effects, which may include nausea, hair loss, and neurotoxicity, as individual responses to the drug can vary significantly. Patients should also be aware of the importance of discussing their complete medical history with their doctor to avoid any harmful interactions. While Biocristin 1 mg Injection can be a vital part of cancer therapy, it is not suitable for everyone, and its use must be carefully considered. By understanding both its benefits and risks, patients can engage more effectively in their treatment journey.
Quantity
Active Pharmaceutical Ingredient
Uses
• Biocristin 1 mg injection is commonly utilized in the treatment of various types of cancer, including brain tumors. It works by disrupting the cancer cells' ability to grow and divide, helping to manage the disease effectively. This makes it an important option for patients facing aggressive brain tumors. Its use can be a part of a comprehensive treatment plan tailored to individual patient needs.
• Another significant application of Biocristin 1 mg injection is in the management of cervical cancer. By targeting the cancer cells, it helps to slow down or halt their progression. This treatment is often combined with other therapies to enhance overall effectiveness. Patients may receive Biocristin 1 mg injection as part of their ongoing care for cervical cancer.
• Biocristin 1 mg injection is also indicated for treating various hematological malignancies, including acute leukemia. Its mechanism of action helps in reducing the number of cancer cells in the blood and bone marrow. This injection plays a crucial role in improving patient outcomes during treatment. Oncologists may recommend Biocristin 1 mg injection based on specific patient conditions.
• Additionally, Biocristin 1 mg injection is effective in treating soft tissue sarcomas, which are cancers that arise in the connective tissues. By inhibiting the growth of these tumors, Biocristin 1 mg injection contributes to better management of the disease. This medication is often part of a multi-modal treatment strategy to optimize patient care. Its versatility makes it a valuable option in the oncologist's arsenal against sarcomas.
Benefits
Biocristin 1 mg Injection is a chemotherapy drug. It is primarily used to treat various types of cancer. It is commonly used to treat acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML), especially when combined with other chemotherapeutic drugs. Its main function is to reduce the presence of leukaemia cells, both in the bone marrow and in the bloodstream. It is also used to treat Hodgkin and non-Hodgkin lymphomas and other lymphoproliferative disorders. It helps to shrink lymphoma tumours. It slows down their growth. It is also used to treat solid cancers such as neuroblastoma, Wilms tumour, rhabdomyosarcoma and Ewing sarcoma. It effectively reduces the size of these tumours. This makes them easier to remove surgically. In children, Biocristin Injection can be used to treat certain brain tumours, including medulloblastoma and ependymoma. It has the potential to help control how the tumour grows and to relieve associated symptoms. In addition, Biocristin 1 mg Injection can be used to treat cancer-related pain. By shrinking tumours that are pressing on nerves or causing discomfort, Biocristin 1 mg Injection can provide pain relief for certain patients. However, it is important to note that while Biocristin 1 mg may offer significant benefits in the treatment of cancer, it may also have potential side effects. For this reason, close monitoring by a team of healthcare professionals is crucial. Common side effects include peripheral neuropathy (tingling or numbness in the extremities), constipation, hair loss and low blood cell count. Patients who are receiving Biocristin 1 mg Injection should be monitored closely for these side effects, and their treatment may be adjusted accordingly to ensure that these problems are managed effectively. It is important to emphasise that Biocristin 1 mg should only be used under the supervision of a qualified oncologist who can assess the risks and benefits specific to each patient.
Side Effects
Like all medicines, this Biocristin 1 mg Injection can cause side effects, although not everybody gets them. Your doctor will discuss these with you and explain the risks and benefits of your treatment.
Most Common Side Effects
• Hair loss
• Headache
• Constipation
• Loss of appetite
• Numbness of feet and arms
• Stomach pain
Common Side Effects
• Severe allergic reaction
• Chest pain
• Breathing problem
• Sepsis
How To Use
Please ensure that Biocristin 1 mg Injection is being administered by a doctor or nurse and do not discontinue use without the advice of your health care professional.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Biocristin 1 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Biocristin 1 mg and report any unusual symptoms or changes in kidney function to their physician. The dose of Biocristin 1 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not known whether Biocristin 1 mg Injection is excreted in human milk. Because many drugs, including other anthracyclines, are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Biocristin 1 mg Injection, lactating women should be advised not to breastfeed during treatment with Biocristin 1 mg and for at least 7 days after last dose.
• Liver: Biocristin 1 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Biocristin 1 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Biocristin 1 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Biocristin 1 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Biocristin 1 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Biocristin 1 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Biocristin 1 mg.